BMC Pregnancy and Childbirth · 2020 · 12 citations · 12 references
MedicineGynecologyObstetricsHemostasisObstetric HemorrhageReproductive MedicineAmniotic Fluid AssessmentAmniotic Fluid EmbolismCoagulation AbnormalitiesCoagulation DisordersPregnancySafe AbortionAmniotic Fluid Embolism ManagementCoagulationGestation PeriodInduced Abortion ComplicationsObstetric Coagulopathy Management
BACKGROUND: Amniotic fluid embolism (AFE) is a rare, life threatening obstetric complication, often associated with severe coagulopathy. Induced abortions are extremely safe procedures however complications including AFE can occur. CASE PRESENTATION: A 29-year-old previously healthy woman, gravida 1 para 0, presented for a scheduled second trimester induced abortion via dilation and evacuation at 22-weeks gestation. The case was complicated by a suspected AFE with associated profound coagulopathy. Viscoelastic point-of-care coagulation analysis was used to successfully and swiftly guide management of her coagulopathy. CONCLUSION: AFE can occur in the setting of induced abortion. This case report suggests viscoelastic point-of-care coagulation analyzers may aid in the management of pregnancy-related coagulopathy by providing faster coagulation assessment than laboratory testing, and facilitating timely, targeted management of coagulopathy.
12
Pregnancy-Related Mortality in the United States, 2011–2013
Andreea A. Creanga, Carla Syverson, Kristi Seed et al. · Obstetrics and Gynecology · 2017 · 1K citations · Full text
Amniotic fluid embolism: diagnosis and management
Luis D. Pacheco, George R. Saade, Gary D.V. Hankins et al. · American Journal of Obstetrics and Gynecology · 2016 · 202 citations
Medicine, Gynecology, Obstetrics +12